Novel Therapeutic Options for Psoriatic Arthritis: 2014 Update

Jointly sponsored by A. Webb Roberts Center for CME of Baylor Health Care System and MedNet.

This activity is supported in part by independent education grants from Janssen Biotech, Inc. and Amgen.

Specialty: Rheumatology

Release date: May 30, 2014

Valid through: May 30, 2015

Target Audience:

This webcast is designed to meet the educational needs of rheumatology specialists and other health care professionals who diagnose, treat, and manage patients with rheumatoid arthritis.

Program Overview:

This webcast is intended to improve care of patients with rheumatoid arthritis by accelerating adoption of new guidelines and evidence-based practice change. In-depth discussion of novel agents at various stages of clinical development will be given significant focus. This Internet CME activity is designed to provide clinical decision-making strategies for integration of novel therapeutic options.

This program consists of N continuing education activites.

Module 1 — Philip Mease, MD — 0.5 AMA PRA Category 1™ Credit Hours

Module 2 — Philip Mease, MD — 0.5 AMA PRA Category 1™ Credit Hours